Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_assertion description "[The NAT2 gene polymorphism was not associated with susceptibility to IBD in Chinese populations, but the NAT2 slow acetylator genotypes were significantly associated with SP dose-related adverse effects of SASP in the treatment of IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_assertion evidence source_evidence_literature NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_assertion SIO_000772 17377643 NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_assertion wasDerivedFrom befree-20150227 NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_assertion wasGeneratedBy ECO_0000203 NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP944349.RAkl7pEwO-bmNu4Jzx4giBFahS0Eq4IHwCMmnVjmmK1hs130_provenance.